Antithrombotic treatment for migraine in patients with patent foramen ovale: multicentre, randomised, active controlled, open label trial
- DOI
- 10.1136/bmj-2026-100103
- Published
- 2026-07-29
- Container
- BMJ
- Publisher
- BMJ
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1136/bmj-2026-100103,
title = {Antithrombotic treatment for migraine in patients with patent foramen ovale: multicentre, randomised, active controlled, open label trial},
author = {Ziping Li and Chuangshi Wang and Yajie Tang and Jing Dong and Jie Dong and Wenbin Ouyang and Fengwen Zhang and Jiahua Pan and Junyi Wan and Yu Han and Kan Yang and Yongsheng Liu and Qinghai Wang and Bo Li and Islamjan Tursun and Qunshan Shen and Shaohui Li and Hengli Lai and Hong Che and Guotao Wang and Qianli Ma and Yongbin Hang and Kai Huang and Youjin Li and Ping Wang and Feng Gao and Wei Liu and Hao Zhang and Hao Hu and Tao You and Huiliang Liu and Lei Chen and Yingzhang Cheng and Caojin Zhang and Rui Wang and Zhisong Chen and Minglian Gong and Qiang Fu and Chuan He and Peijian Wang and Chunjian Shen and Hongwen Tan and Xiaojun Zhang and Xueqin Zhang and Rui Zhang and Yongjun Wang and Xiangbin Pan},
year = {2026},
journal = {BMJ},
doi = {10.1136/bmj-2026-100103},
url = {https://doi.org/10.1136/bmj-2026-100103}
}RIS
TY - JOUR TI - Antithrombotic treatment for migraine in patients with patent foramen ovale: multicentre, randomised, active controlled, open label trial AU - Ziping Li AU - Chuangshi Wang AU - Yajie Tang AU - Jing Dong AU - Jie Dong AU - Wenbin Ouyang AU - Fengwen Zhang AU - Jiahua Pan AU - Junyi Wan AU - Yu Han AU - Kan Yang AU - Yongsheng Liu AU - Qinghai Wang AU - Bo Li AU - Islamjan Tursun AU - Qunshan Shen AU - Shaohui Li AU - Hengli Lai AU - Hong Che AU - Guotao Wang AU - Qianli Ma AU - Yongbin Hang AU - Kai Huang AU - Youjin Li AU - Ping Wang AU - Feng Gao AU - Wei Liu AU - Hao Zhang AU - Hao Hu AU - Tao You AU - Huiliang Liu AU - Lei Chen AU - Yingzhang Cheng AU - Caojin Zhang AU - Rui Wang AU - Zhisong Chen AU - Minglian Gong AU - Qiang Fu AU - Chuan He AU - Peijian Wang AU - Chunjian Shen AU - Hongwen Tan AU - Xiaojun Zhang AU - Xueqin Zhang AU - Rui Zhang AU - Yongjun Wang AU - Xiangbin Pan PY - 2026 JO - BMJ DO - 10.1136/bmj-2026-100103 UR - https://doi.org/10.1136/bmj-2026-100103 ER -
APA
Li, Z., Wang, C., Tang, Y., Dong, J., Dong, J., Ouyang, W., Zhang, F., Pan, J., Wan, J., Han, Y., Yang, K., Liu, Y., Wang, Q., Li, B., Tursun, I., Shen, Q., Li, S., Lai, H., Che, H., Wang, G., Ma, Q., Hang, Y., Huang, K., Li, Y., Wang, P., Gao, F., Liu, W., Zhang, H., Hu, H., You, T., Liu, H., Chen, L., Cheng, Y., Zhang, C., Wang, R., Chen, Z., Gong, M., Fu, Q., He, C., Wang, P., Shen, C., Tan, H., Zhang, X., Zhang, X., Zhang, R., Wang, Y., & Pan, X. (2026). Antithrombotic treatment for migraine in patients with patent foramen ovale: multicentre, randomised, active controlled, open label trial. BMJ. https://doi.org/10.1136/bmj-2026-100103
Source records
- crossref · retrieved 2026-09-26T12:06:58.770Z